 Complete tumor assessments including gadolinium enhanced brain MRI will be repeated at Week 8 on Cycle 3 Day 1 and every 8 weeks i.e. every 2 cycles thereafter or earlier if clinically indicated. Safety evaluations will include SAEs, physical examination, vital signs, ECGs, laboratory parameters and WHO performance status. Blood and CSF samples for PK will also be collected. 